In this episode, the Technology Networks team discuss drug treatments to combat COVID-19. These drugs, like the anti-malarial hydroxychloroquine, have often been repurposed for the task, and evidence for their efficacy remains patchy. Why do researchers turn to these medications and how will the field of drug development be changed by the COVID-19 pandemic? Read more from this podcast: Hydroxychloroquine Revived by WHOHow modeling can support drug developmentCovid-19 brings drug development to a haltTackling Covid-19: ongoing drug development effortsFlooded by the torrent: the COVID-19 drug pipelineGlobal impact on clinical trialsWhat is a preprint? Exploring the drug development processKeep up to date with COVID-19 vaccine developmentUpdates:Hydroxychloroquine arm stopped in RECOVERY Trial
Podden och tillhörande omslagsbild på den här sidan tillhör technologynetworks. Innehållet i podden är skapat av technologynetworks och inte av, eller tillsammans med, Poddtoppen.